Atlas Trials

A Phase 1 Study of PV-001 9-valent Human Papillomavirus(HPV) Vaccine

Clinical trial NCT07081334 · COMPLETED

Trial details

NCT number
NCT07081334
Sponsor
POSVAX
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
HPV Infections
Start date
2022-08-17
Primary completion
2024-04-29
Enrollment
41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.